Program News
News and stories about the UNC Lineberger Pediatric Hematology-Oncology Program
-
Umbilical cord blood donation saved 1-year-old boy’s life
Many people don’t realize that extracting and donating the nutrient-rich blood from the umbilical cord can save someone else’s life, as it did for 1-year-old Cole Baranowski.
-
Nanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor
In a laboratory study, UNC Lineberger researchers report a novel combination of two drugs delivered in a nanoparticle formulation may suggest an approach for a less toxic treatment for medulloblastoma, the most common pediatric brain cancer.
-
Researchers discover gene linked to bone cancer in children, identify potential novel therapy
Pengda Liu, PhD, Ian Davis, MD, PhD, and colleagues have discovered a gene, OTUD7A, that impacts the development of Ewing sarcoma, as well as a compound that shows potential to block OTUD7A protein activity.
-
Donor gift shows support for family, innovative therapy
Wade’s Army supports families with needs related to a neuroblastoma diagnosis, and supports research and science into finding a cure for the disease.
-
Gold honored as Triangle Business Journal 2020 Health Care Hero
The Triangle Business Journal named UNC Lineberger’s Stuart Gold, MD, as one of its 2020 Health Care Heroes.
-
Researchers identify possible approach to block medulloblastoma growth
UNC Lineberger researchers have identified a potential approach to stop the growth of medulloblastoma, the most common type of brain tumor in children.
-
Holbrook calls for support to give kids like his son a ‘fighting chance’
At the 15th annual Roy Williams Fast Break against Cancer, Chad Holbrook offered a compelling reason why to support UNC Lineberger and its mission: the health of his son Reece, who is a cancer survivor and a top prospect high school baseball player.
-
Hyundai Hope On Wheels awards Smitherman $200,000 grant to support cancer outcomes research in children, adolescents and young adults
Andrew Smitherman, MD, MSc, was awarded a two-year, $200,000 Hyundai Young Investigator Grant to investigate approaches to identify pediatric, adolescent and young adult cancer patients most at risk for late stage treatment side-effects.